26 Sep 2017 | 8:57 PM
 

Cadila Healthcare Ltd. Share Price Live (BSE)
0

BSE Code: 532321 | NSE Symbol: CADILAHC
474.00
-7.55
(-1.56 %)
26 Sep 2017 | 03:55 PM
Change company
  • Open (Rs)
    477.00
  • Prev. close (Rs.)
    481.55
  • High (Rs.)
    485.10
  • Low (Rs.)
    472.00
  • 52W H (Rs.)
    558.00
  • 52W L (Rs.)
    329.95
  • Volume (Rs.)
    61187
  • MCap (Rs in Cr.)
    48,525.42

Stock Market News

Cadila Healthcare Ltd. Stock News

Company Name
From Date
To Date
  Cadila Healthcare Ltd. | 25 Sep 2017 | 10:09:00
Zydus Cadila has said that it has received the final approval from the USFDA to market Amlodipine and Olmesartan Medoxomil Tablets in strengths of 5 mg/20 mg 5 mg/40 mg 10 mg/20 mg and 10 mg/40 mg ...
  Cadila Healthcare Ltd. | 19 Sep 2017 | 15:05:00
Cadila Healthcare Limited an innovation-driven global healthcare company has said that it has entered into an exclusive agreement for the technology know-how for varicella vaccine production in the Russian Federation with Pharm Aid Ltd...
  Cadila Healthcare Ltd. | 18 Sep 2017 | 12:05:00
Shares of Cadila Healthcare rose 2 per cent on the Bombay Stock Exchange after the drug major said that its arm Nesher Pharmaceuticals has received final approval from the USFDA to market Oseltamivir Powder for Oral Suspension 6 mg/ml which is used in the ...
  Cadila Healthcare Ltd. | 18 Sep 2017 | 09:22:00
Zydus Cadila has said that its arm Nesher Pharmaceuticals has received final approval from the USFDA to market Oseltamivir Powder for Oral Suspension 6 mg/ml which is used in the treatment and prevention of influenza...
  Cadila Healthcare Ltd. | 07 Sep 2017 | 15:06:00
Cadila Healthcare said that it has received zero observations from the US health regulator for Moraiya plant...
  Cadila Healthcare Ltd. | 07 Sep 2017 | 15:06:00
Cadila Healthcare said that it has received zero observations from the US health regulator for Moraiya plant...
  Cadila Healthcare Ltd. | 07 Sep 2017 | 14:59:00
Shares of Cadila Healthcare surged over 3 per cent on the Bombay Stock Exchange after getting zero observations from the US health regulator for Moraiya plant...
  Cadila Healthcare Ltd. | 07 Sep 2017 | 14:59:00
Shares of Cadila Healthcare surged over 3 per cent on the Bombay Stock Exchange after getting zero observations from the US health regulator for Moraiya plant...
  Cadila Healthcare Ltd. | 04 Sep 2017 | 09:30:00
Zydus Cadila has said that it has received the final approval from the USFDA to market Mycophenolate Mofetil for Injection USP 500 mg/vial.


“The drug is indicated for use in combination with other drugs i.e...

  Cadila Healthcare Ltd. | 04 Sep 2017 | 09:30:00
Zydus Cadila has said that it has received the final approval from the USFDA to market Mycophenolate Mofetil for Injection USP 500 mg/vial.


“The drug is indicated for use in combination with other drugs i.e...

  Cadila Healthcare Ltd. | 01 Sep 2017 | 14:03:00
Zydus Cadila has said that it has received the final approval from the USFDA to market Donepezil Hydrochloride tablets in the strength of 23 mg. The drug is indicated for the treatment of dementia of the Alzheimer’s disease...
  Cadila Healthcare Ltd. | 01 Sep 2017 | 14:03:00
Zydus Cadila has said that it has received the final approval from the USFDA to market Donepezil Hydrochloride tablets in the strength of 23 mg. The drug is indicated for the treatment of dementia of the Alzheimer’s disease...
  Cadila Healthcare Ltd. | 30 Aug 2017 | 12:16:00
Shares of Cadila Healthcare rose 3 per cent on the Bombay Stock Exchange after the company said that Zydus Cadila receives final approval from the USFDA for Aspirin and Extended-Release Dipyridamole Capsules...
  Cadila Healthcare Ltd. | 30 Aug 2017 | 12:16:00
Shares of Cadila Healthcare rose 3 per cent on the Bombay Stock Exchange after the company said that Zydus Cadila receives final approval from the USFDA for Aspirin and Extended-Release Dipyridamole Capsules...
  Cadila Healthcare Ltd. | 30 Aug 2017 | 10:57:00
Pharma major Zydus Cadila said that it has received the final approval from the USFDA to market Aspirin and Extended-Release Dipyridamole Capsules in the strength of 25 mg/200 mg...
  Cadila Healthcare Ltd. | 30 Aug 2017 | 10:57:00
Pharma major Zydus Cadila said that it has received the final approval from the USFDA to market Aspirin and Extended-Release Dipyridamole Capsules in the strength of 25 mg/200 mg...
  Cadila Healthcare Ltd. | 29 Aug 2017 | 12:12:00
Pharma major Cadila Healthcare said that it has received EIR Report for Manufacturing Facility at the Pharma SEZ at Ahmedabad...
  Cadila Healthcare Ltd. | 29 Aug 2017 | 12:12:00
Pharma major Cadila Healthcare said that it has received EIR Report for Manufacturing Facility at the Pharma SEZ at Ahmedabad...

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Cadila Healthcare Ltd. that will help you decide whether to buy, sell or hold Cadila Healthcare Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Cadila Healthcare Ltd.